Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Don2018on Oct 17, 2019 9:19am

139 Views

Post# 30239494

RE:RE:RE:RE:RE:RE:Trading

MirrorWorldMan wrote: I was hoping to see a bit more details from R + F yesterday, based on the NR.

This is a small deal for R&F, while a huge deal for SBM.

So who do you think should be putting news out?

Your "soft" bashing is getting to the point of simply being boring.

R&F will talk about it when they launch the new product, and then they will talk about it a LOT.

Bullboard Posts

A junior copper-gold stock trading at a bargain of monumental proportions